US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Conexeu Sciences Inc.

2.54

-0.2900-10.25%

Post-market: 2.640.1048+4.13%19:46 EDT

Volume:518.84K

Turnover:1.34M

Market Cap:71.65M

PE:-5.11

High:2.85

Open:2.85

Low:2.43

Close:2.83

52wk High:18.79

52wk Low:2.43

Shares:28.21M

Float Shares:16.81M

Volume Ratio:1.79

T/O Rate:3.09%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.4970

EPS(LYR):-0.3104

ROE:-332.94%

ROA:-170.73%

PB:12.25

PE(LYR):-8.18

Loading ...

Overview Company News Filings

Conexeu Sciences Offers New Warrants to Encourage Early Exercise of up to 4,762,780 Warrants

Conexeu Sciences Independent Director Acquires 5.6% More Stock

Simply Wall St.

Conexeu Sciences Raises $4.75 Million in Private Placement

Conexeu Sciences Director Lynn Sebastian Purcell Reports $499,998 Common Share Acquisition

Conexeu Sciences Secures $5 Million Insider-Led Funding for FDA Push

Conexeu Sciences Closes $5 Million Private Placement

Conexeu Sciences Announces $5 Million Private Placement Led by Existing Shareholders, Management and Directors

THOMSON REUTERS

Conexeu Sciences Shares Rise on Advancement of Tissue Restoration Platform

Conexeu provides update on FDA 510 premarket notification for Ten Minute Tissue

Conexeu Sciences Advances Ten Minute Tissue™ Toward Planned FDA 510(k) Submission

THOMSON REUTERS

Conexeu Sciences Issues 762,608 Unregistered Shares at Us$2.3 in Warrant Exercise Incentive Program

Conexeu Sciences to Present at Nasdaq/LD Micro Summit Series

Conexeu Sciences Sets September and October 2026 Conference Schedule

Conexeu Says CXU Preclinical Program Completes 12-Month P.r.o.o.f. Phase, Meets Objectives

Conexeu Sciences Sees a New Category Forming in Medical Aesthetics as Research Turns to Regeneration

Conexeu Highlights ECM-Based Regenerative Platform Ahead of 2026 Aesthetics Symposium

Conexeu Sciences CMO Presents on Extracellular Matrix Role in Tissue Regeneration at Laser & Cosmetic Surgery Symposium

Conexeu Sciences Announces Press Release Availability

Conexeu Sciences Completes 12-month Preclinical Study for CXU Tissue-restoration Platform

Conexeu Sciences Notifies Availability of Press Release

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/CNXU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CNXU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNXU\",,,,,undefined,":{"symbol":"CNXU","market":"US","secType":"STK","nameCN":"Conexeu Sciences Inc.","latestPrice":2.54,"timestamp":1793390400000,"preClose":2.83,"halted":0,"volume":518841,"hourTrading":{"tag":"盘后","latestPrice":2.6448,"preClose":2.54,"latestTime":"19:46 EDT","volume":4774,"amount":12374.6771,"timestamp":1793403987930,"change":0.1048,"changeRate":0.04126,"amplitude":0.049803},"delay":0,"changeRate":-0.10247349823321555,"floatShares":16805664,"shares":28206698,"eps":-0.497,"marketStatus":"Market Closed","change":-0.29,"latestTime":"10-30 16:00:00 EDT","open":2.85,"high":2.85,"low":2.43,"amount":1341444.208383,"amplitude":0.14841,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.497,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1793610000000},"marketStatusCode":7,"adr":0,"listingDate":1779336000000,"exchange":"NASDAQ","adjPreClose":2.83,"preHourTrading":{"tag":"盘前","latestPrice":2.8268,"preClose":2.83,"latestTime":"09:27 EDT","volume":784,"amount":2241.3039823999998,"timestamp":1793366866154,"change":-0.0032,"changeRate":-0.001131,"amplitude":0.025866},"postHourTrading":{"tag":"盘后","latestPrice":2.6448,"preClose":2.54,"latestTime":"19:46 EDT","volume":4774,"amount":12374.6771,"timestamp":1793403987930,"change":0.1048,"changeRate":0.04126,"amplitude":0.049803},"volumeRatio":1.7932722353429582},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNXU\",,,,,undefined,":{"symbol":"CNXU","floatShares":16805664,"roa":"-170.73%","roe":"-332.94%","lyrEps":-0.310358,"volumeRatio":1.7932722353429582,"shares":28206698,"dividePrice":0,"high":2.85,"amplitude":0.14841,"preClose":2.83,"low":2.43,"week52Low":2.43,"pbRate":"12.25","week52High":18.7915,"institutionHeld":0,"latestPrice":2.54,"eps":-0.497,"divideRate":0,"volume":518841,"delay":0,"ttmEps":-0.497,"open":2.85,"prevYearClose":13.5,"prevWeekClose":3.1,"prevMonthClose":3.57,"prevQuarterClose":3.57,"fiveDayClose":3.1,"twentyDayClose":3.1,"sixtyDayClose":8.47},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CNXU\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-09-14","symbol":"CNXU","fiscalQuarterEnding":"2026/07","expectedEps":-0.1,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1789358400000,"reportTimeType":"post","actualEps":-0.29}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CNXU\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CNXU\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1782187200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CNXU\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CNXU","date":"2026-10-14","current":-5.110664,"percent":0.979592,"low":-79.55424,"twenty":-49.139497,"median":-33.045764,"eighty":-17.334212,"high":-6.417374,"avg":-33.866575,"sd":18.950859,"marketCap":93364170},"quantilePoints":[{"date":"2026-05-22","current":-61.707651,"twenty":-61.707651,"median":-61.707651,"eighty":-61.707651,"marketCap":330278847},{"date":"2026-05-29","current":-54.672884,"twenty":-65.607461,"median":-64.327983,"eighty":-60.300698,"marketCap":292626553},{"date":"2026-06-05","current":-75.541118,"twenty":-76.3343,"median":-65.838806,"eighty":-60.437616,"marketCap":404319936},{"date":"2026-06-12","current":-57.26961,"twenty":-72.783868,"median":-65.815199,"eighty":-60.63119,"marketCap":306525051},{"date":"2026-06-18","current":-61.471585,"twenty":-72.022319,"median":-64.327983,"eighty":-56.504756,"marketCap":329015347},{"date":"2026-06-26","current":-37.989619,"twenty":-69.581868,"median":-61.589618,"eighty":-54.125211,"marketCap":273470132},{"date":"2026-07-02","current":-38.138306,"twenty":-67.458218,"median":-61.182094,"eighty":-40.651122,"marketCap":274540465},{"date":"2026-07-10","current":-36.837292,"twenty":-66.325102,"median":-57.26961,"eighty":-39.424451,"marketCap":265175050},{"date":"2026-07-17","current":-39.067602,"twenty":-65.494149,"median":-53.988293,"eighty":-38.257256,"marketCap":281230048},{"date":"2026-07-24","current":-34.012232,"twenty":-64.738738,"median":-41.558115,"eighty":-37.945013,"marketCap":244838719},{"date":"2026-07-31","current":-32.822733,"twenty":-64.002212,"median":-40.591647,"eighty":-36.004643,"marketCap":236276053},{"date":"2026-08-07","current":-31.484547,"twenty":-62.500833,"median":-39.94114,"eighty":-34.153485,"marketCap":226643055},{"date":"2026-08-14","current":-29.625955,"twenty":-61.660438,"median":-39.067602,"eighty":-32.859905,"marketCap":213263890},{"date":"2026-08-21","current":-35.053043,"twenty":-61.471585,"median":-38.101134,"eighty":-33.023461,"marketCap":252331051},{"date":"2026-08-28","current":-26.168974,"twenty":-61.355789,"median":-37.989619,"eighty":-31.008748,"marketCap":188378643},{"date":"2026-09-04","current":-19.589559,"twenty":-60.536268,"median":-36.985979,"eighty":-29.090681,"marketCap":141016399},{"date":"2026-09-11","current":-15.798031,"twenty":-59.110925,"median":-36.446988,"eighty":-28.547972,"marketCap":113722902},{"date":"2026-09-18","current":-20.767449,"twenty":-57.26961,"median":-35.313246,"eighty":-27.023926,"marketCap":149495499},{"date":"2026-09-25","current":-8.197678,"twenty":-55.357476,"median":-34.88577,"eighty":-25.927357,"marketCap":111698524},{"date":"2026-10-02","current":-6.872801,"twenty":-54.672884,"median":-33.752029,"eighty":-19.589559,"marketCap":93646237},{"date":"2026-10-09","current":-7.141916,"twenty":-53.303701,"median":-33.194451,"eighty":-18.474404,"marketCap":97313108},{"date":"2026-10-14","current":-6.852099,"twenty":-49.139497,"median":-33.045764,"eighty":-17.334212,"marketCap":93364170}],"updateTime":1793466877378},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CNXU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2678498486","title":"Conexeu Sciences Offers New Warrants to Encourage Early Exercise of up to 4,762,780 Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2678498486","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678498486?lang=en_us&edition=fundamental","pubTime":"2026-10-28 04:53","pubTimestamp":1793134385,"startTime":"0","endTime":"0","summary":"Conexeu Sciences offers new warrants to encourage early exercise of up to 4,762,780 warrantsConexeu Sciences launched an incentive program for early exercise of up to 4,762,780 warrants at USD 2.30 pe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261027:nNDL6d7Q4r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNXU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677601071","title":"Conexeu Sciences Independent Director Acquires 5.6% More Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2677601071","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677601071?lang=en_us&edition=fundamental","pubTime":"2026-10-22 02:31","pubTimestamp":1792607508,"startTime":"0","endTime":"0","summary":"Potential Conexeu Sciences Inc. ( NASDAQ:CNXU ) shareholders may wish to note that the Independent Director, Sebastian...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cnxu/conexeu-sciences/news/conexeu-sciences-independent-director-acquires-56-more-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cnxu/conexeu-sciences/news/conexeu-sciences-independent-director-acquires-56-more-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CNXU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677561913","title":"Conexeu Sciences Raises $4.75 Million in Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2677561913","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677561913?lang=en_us&edition=fundamental","pubTime":"2026-10-21 04:32","pubTimestamp":1792528338,"startTime":"0","endTime":"0","summary":"Conexeu Sciences Raises $4.75 Million in Private PlacementConexeu Sciences raised $4.75 million in a private placement that closed October 15, 2026, for working capital and general corporate purposes.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261020:nNDL4KD7gJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676636725","title":"Conexeu Sciences Director Lynn Sebastian Purcell Reports $499,998 Common Share Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2676636725","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676636725?lang=en_us&edition=fundamental","pubTime":"2026-10-20 04:49","pubTimestamp":1792442989,"startTime":"0","endTime":"0","summary":"Conexeu Sciences Director Lynn Sebastian Purcell Reports $499,998 Common Share AcquisitionConexeu Sciences director and 10% owner Lynn Sebastian Purcell acquired 166,666 common shares.Purcell also acq","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261019:nNDL1rBQM2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Conexeu Sciences Director Lynn Sebastian Purcell Reports $499,998 Common Share Acquisition","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675558124","title":"Conexeu Sciences Secures $5 Million Insider-Led Funding for FDA Push","url":"https://stock-news.laohu8.com/highlight/detail?id=2675558124","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675558124?lang=en_us&edition=fundamental","pubTime":"2026-10-16 05:09","pubTimestamp":1792098579,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Conexeu Sciences, Inc. ( ($CNXU) ). Conexeu Sciences has raised approximately $5 million in a private placement...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/conexeu-sciences-secures-5-million-insider-led-funding-for-fda-push?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/conexeu-sciences-secures-5-million-insider-led-funding-for-fda-push?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4139","CNXU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675305465","title":"Conexeu Sciences Closes $5 Million Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2675305465","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675305465?lang=en_us&edition=fundamental","pubTime":"2026-10-16 04:31","pubTimestamp":1792096285,"startTime":"0","endTime":"0","summary":"Conexeu Sciences Closes $5 Million Private PlacementConexeu Sciences closed an approximately $5 million private placement led by existing shareholders, including management and directors.The offering ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261015:nNDLbyVp8r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3C00.GBP","SG9999014005.SGD","SG9999014013.SGD","BCDF","IE00B64PRP62.GBP","IE00BKPKM429.USD","IE00BN0W2V16.EUR","LU2210150020.SGD","IE00BQXX3F31.USD","NDAQ","IE00BN0W2W23.USD","BK4585","IE00BGHQF748.EUR","LU2095319765.USD","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","LU2210149790.SGD","BK4139","IE00BQXX3D17.EUR","SG9999014021.USD","SG9999014039.USD","LU0314104364.USD","BK4112","CNXU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675453058","title":"Conexeu Sciences Announces $5 Million Private Placement Led by Existing Shareholders, Management and Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2675453058","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675453058?lang=en_us&edition=fundamental","pubTime":"2026-10-16 04:30","pubTimestamp":1792096200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261015:nTUA2PFBMT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CNXU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673231068","title":"Conexeu Sciences Shares Rise on Advancement of Tissue Restoration Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2673231068","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673231068?lang=en_us&edition=fundamental","pubTime":"2026-10-07 03:13","pubTimestamp":1791313980,"startTime":"0","endTime":"0","summary":"Shares of Conexeu Sciences rose after the medical device and regenerative medicine company reported progress for its CXU tissue restoration platform.The stock was up 11% to $3.45 in Tuesday afternoon trading. Shares have traded in range of $3.05 to $18.79 since their debut on Nasdaq via a direct listing.The company said it has advanced manufacturing scale-up, regulatory testing and preclinical work supporting a planned 510 submission to the Food and Drug Administration in the first quarter of 2027.Multiple scaled-up batches of CXU material met company specifications for key material characteristics and product performance measures, the company said.CXU is a collagen-based extracellular matrix platform.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Conexeu Sciences Shares Rise on Advancement of Tissue Restoration Platform","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673051138","title":"Conexeu provides update on FDA 510 premarket notification for Ten Minute Tissue","url":"https://stock-news.laohu8.com/highlight/detail?id=2673051138","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673051138?lang=en_us&edition=fundamental","pubTime":"2026-10-06 21:12","pubTimestamp":1791292341,"startTime":"0","endTime":"0","summary":"Conexeu Sciences (CNXU) provided an update on the regulatory and manufacturing program supporting its planned FDA 510 premarket notification for Te...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/conexeu-provides-update-on-fda-510-premarket-notification-for-ten-minute-tissue-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/conexeu-provides-update-on-fda-510-premarket-notification-for-ten-minute-tissue-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EES","BK4588","CNXU","BK4139","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673605985","title":"Conexeu Sciences Advances Ten Minute Tissue™ Toward Planned FDA 510(k) Submission","url":"https://stock-news.laohu8.com/highlight/detail?id=2673605985","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673605985?lang=en_us&edition=fundamental","pubTime":"2026-10-06 20:30","pubTimestamp":1791289802,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nTUA5RT5KF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CNXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666515287","title":"Conexeu Sciences Issues 762,608 Unregistered Shares at Us$2.3 in Warrant Exercise Incentive Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2666515287","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666515287?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:32","pubTimestamp":1789072347,"startTime":"0","endTime":"0","summary":"Conexeu Sciences issues 762,608 unregistered shares at US$2.3 in warrant exercise incentive programConexeu Sciences issued 1,448,368 unregistered common shares from June 18 to Sept. 4, triggering a Fo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL4NVDQ6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNXU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664485945","title":"Conexeu Sciences to Present at Nasdaq/LD Micro Summit Series","url":"https://stock-news.laohu8.com/highlight/detail?id=2664485945","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664485945?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:32","pubTimestamp":1788265947,"startTime":"0","endTime":"0","summary":"Conexeu Sciences to present at Nasdaq/LD Micro Summit SeriesConexeu will attend the Nasdaq / LD Micro Summit Series on Sept. 9, 2026 in San Francisco.Management is also scheduled for the H.C. Wainwrig","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDLcfCHgF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","IE00BN0W2W23.USD","IE00BQXX3C00.GBP","SG9999014039.USD","BK4585","BK4112","LU2210149790.SGD","IE00BKPKM429.USD","IE00BQXX3F31.USD","IE00B3QW5Z07.USD","BK4139","CNXU","SG9999014013.SGD","LU2095319765.USD","IE00BN0W2T93.GBP","LU0314104364.USD","IE00B64PRP62.GBP","BK4588","NDAQ","SG9999014005.SGD","IE00BQXX3D17.EUR","IE00BGHQF748.EUR","BCDF","SG9999014021.USD","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664851209","title":"Conexeu Sciences Sets September and October 2026 Conference Schedule","url":"https://stock-news.laohu8.com/highlight/detail?id=2664851209","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664851209?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:30","pubTimestamp":1788265800,"startTime":"0","endTime":"0","summary":"RENO, Nev., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Conexeu Sciences Inc. (Nasdaq: CNXU) (“Conexeu” or the “Company”), a preclinical-stage biotechnology company advancing an investigational tissue-restora","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354163/0/en/conexeu-sciences-sets-september-and-october-2026-conference-schedule.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660674844","title":"Conexeu Says CXU Preclinical Program Completes 12-Month P.r.o.o.f. Phase, Meets Objectives","url":"https://stock-news.laohu8.com/highlight/detail?id=2660674844","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660674844?lang=en_us&edition=fundamental","pubTime":"2026-08-18 20:55","pubTimestamp":1787057729,"startTime":"0","endTime":"0","summary":"Conexeu says CXU preclinical program completes 12-month P.R.O.O.F. phase, meets objectivesConexeu disclosed completion of the 12-month P.R.O.O.F. phase in its CXU preclinical program for an ECM-based ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL5hTz5g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNXU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660467389","title":"Conexeu Sciences Sees a New Category Forming in Medical Aesthetics as Research Turns to Regeneration","url":"https://stock-news.laohu8.com/highlight/detail?id=2660467389","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660467389?lang=en_us&edition=fundamental","pubTime":"2026-08-18 20:30","pubTimestamp":1787056200,"startTime":"0","endTime":"0","summary":"Peer-reviewed research points to the extracellular matrix, the framework that holds tissue together, as central to that work. More than a decade of research has gone into Conexeu’s CXU Platform Highli","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/18/3346816/0/en/conexeu-sciences-sees-a-new-category-forming-in-medical-aesthetics-as-research-turns-to-regeneration.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658505916","title":"Conexeu Highlights ECM-Based Regenerative Platform Ahead of 2026 Aesthetics Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2658505916","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658505916?lang=en_us&edition=fundamental","pubTime":"2026-08-11 22:02","pubTimestamp":1786456969,"startTime":"0","endTime":"0","summary":"Conexeu Sciences, Inc. ( ($CNXU) ) just unveiled an announcement. Conexeu Sciences, a regenerative tissue platform specialist, is building its CXU ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/conexeu-highlights-ecm-based-regenerative-platform-ahead-of-2026-aesthetics-symposium?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/conexeu-highlights-ecm-based-regenerative-platform-ahead-of-2026-aesthetics-symposium?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CNXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658368918","title":"Conexeu Sciences CMO Presents on Extracellular Matrix Role in Tissue Regeneration at Laser & Cosmetic Surgery Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2658368918","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658368918?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:32","pubTimestamp":1786451547,"startTime":"0","endTime":"0","summary":"Conexeu Sciences CMO presents on extracellular matrix role in tissue regeneration at Laser & Cosmetic Surgery symposiumConexeu will present at the Controversies & Conversations in Laser & Cosmetic Sur","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL8gBbQS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2095319765.USD","IE00BN0W2W23.USD","IE00B64PRP62.GBP","SG9999014039.USD","IE00BKPKM429.USD","LU0314104364.USD","CNXU","IE00BN0W2T93.GBP","BK4588","LU2210150020.SGD","SG9999014005.SGD","BCDF","BK4585","BK4112","SG9999014021.USD","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","SG9999014013.SGD","BK4139","NDAQ","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651110567","title":"Conexeu Sciences Announces Press Release Availability","url":"https://stock-news.laohu8.com/highlight/detail?id=2651110567","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651110567?lang=en_us&edition=fundamental","pubTime":"2026-07-14 20:31","pubTimestamp":1784032311,"startTime":"0","endTime":"0","summary":"Conexeu Sciences announces press release availabilityConexeu released an update on its CXU tissue-restoration platform, citing completion of a 12-month P.R.O.O.F. preclinical study.Focus is large-volu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDLc1zG4s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","CNXU","BK4588","NDAQ","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","SG9999014039.USD","BK4112","LU2095319765.USD","LU2210149790.SGD","BK4139","IE00B3QW5Z07.USD","IE00BKPKM429.USD","BCDF","IE00BGHQF748.EUR","SG9999014021.USD","SG9999014013.SGD","BK4585","LU2210150020.SGD","IE00BN0W2T93.GBP","LU0314104364.USD","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649195853","title":"Conexeu Sciences Completes 12-month Preclinical Study for CXU Tissue-restoration Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2649195853","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649195853?lang=en_us&edition=fundamental","pubTime":"2026-07-08 05:13","pubTimestamp":1783458831,"startTime":"0","endTime":"0","summary":"Conexeu Sciences completes 12-month preclinical study for CXU tissue-restoration platformConexeu completed its 12-month P.R.O.O.F preclinical study for the CXU platform, a key milestone ahead of plann","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDL92bnq6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649938802","title":"Conexeu Sciences Notifies Availability of Press Release","url":"https://stock-news.laohu8.com/highlight/detail?id=2649938802","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649938802?lang=en_us&edition=fundamental","pubTime":"2026-07-07 21:01","pubTimestamp":1783429306,"startTime":"0","endTime":"0","summary":"Conexeu Sciences notifies availability of press releaseConexeu published a release reporting completion of its 12-month P.R.O.O.F preclinical program for the CXU platform.Results met study objectives ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDL8HbHGg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","IE00BN0W2V16.EUR","BK4139","SG9999014021.USD","BCDF","IE00BN0W2T93.GBP","SG9999014013.SGD","BK4112","LU2210150020.SGD","LU2210149790.SGD","SG9999014005.SGD","IE00B64PRP62.GBP","BK4585","IE00BN0W2W23.USD","BK4588","SG9999014039.USD","NDAQ","IE00BGHQF748.EUR","LU2095319765.USD","LU0314104364.USD","IE00B3QW5Z07.USD","CNXU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":43,"code":"91000000","status":"200"}]}}